X0202 4/A 2004-04-14 2004-06-17 0 0000761237 IMCOR PHARMACEUTICAL CO ICPHC 0001140484 OXFORD BIOSCIENCE PARTNERS IV LP 222 BERKELEY STREET, SUITE 1650 BOSTON MA 02216 0 0 1 0 Common Stock 2004-04-14 4 P 0 5445365 0.4 A 11862462 D Common Stock 2004-04-14 4 P 0 9654004 0.4 A 21516466 D Common Stock 2004-04-19 4 P 0 21816916 0.4 A 43333382 D Revolving Convertible Senior Secured Promissory Notes 2004-04-14 4 S 0 3861601.50 0.4 D 0 D Secured Promissory Notes 2004-04-19 4 S 0 8726766.55 0.4 D 0 D Warrants to Purchase Common Stock 0.5 2004-04-14 4 P 0 2722683 0 A 2004-04-14 2009-04-14 Common Stock 2722683 2722683 D On April 14, 2004, Oxford agreed to purchase 568,678 shares of common stock at a price of $0.75 per share. On April 19, 2004, the first of two closings occurred and the shares mentioned in the previous sentence were issued. On June 30, 2004, the second closing occurred and the entire transaction (including the April 19, 2004 and June 30, 2004 closings) was re-priced at $0.40 per share. Based on the revised terms, 4,876,687 shares were issued to Oxford on June 30, 2004. On April 14, 2004, Oxford agreed to convert convertible notes in the aggregate amount of $3,861,601.51 at a conversion price of $0.75 per share. This conversion resulted in the acquisition of 5,148,802 shares by Oxford. On June 30, 2004, in connection with the second closing and the re-pricing of the shares at $0.40 per share, an additional 4,505,202 shares were issued to Oxford. On June 30, 2004, in connection with the second closing, Oxford converted secured notes in the aggregate of $8,726,766.55 at a price of $0.40 per share, which resulted in its acquisition of 21,816,916 shares of common stock. On April 19, 2004 in connection with the first closing, Oxford acquired warrants to purchase 284,339 shares of common stock. In connection with the second closing on June 30, 2004, Oxford acquired warrants to purchase an additional 2,438,344 shares of common stock. /s/ Alexia Pearsall, under power of attorney for Jonathan Fleming, general partner of OBP Management IV L.P., its general partner 2004-07-02